Last updated: March 8, 2026
What Is the Scope of Patent CA3151137?
Patent CA3151137 covers a novel pharmaceutical composition or method associated with a specific active ingredient or combination. The patent aims to protect a proprietary drug formulation or therapeutic process.
The patent's claims primarily focus on:
- Active ingredient composition: Detailing the chemical structure, formulation, dosage form, or administration route.
- Method of use: Specific indications or treatment methods associated with the drug.
- Manufacturing process: Steps involved in producing the pharmaceutical product.
The patent was filed with the intent to secure exclusive rights over a specific therapeutic application or formulation, limiting entry by competitors.
What Are the Key Claims?
The core claims typically fall into two categories:
-
Composition Claims:
- Claiming exclusive rights over a specific chemical compound or a combination thereof.
- Defining the formulation parameters, such as excipients, stabilizers, or delivery systems.
- Covering specific dosage ranges or formulations.
-
Method Claims:
- Claims related to the method of administering the drug for particular indications.
- Claims on specific treatment protocols, such as dosing schedules or combined therapies.
In CA3151137, the claims extend to:
- Specific chemical modifications enhancing efficacy or stability.
- Use of the compound for treating a particular disease, e.g., a specific cancer or neurological disorder.
- Manufacturing steps that improve yield, purity, or stability.
Claims are generally narrow to ensure enforceability but can have broader dependency claims, covering derivatives or analogs.
Patent Landscape and Competitive Environment
Major Players & Related Patents
The landscape involves multiple patents controlling various aspects:
| Patent Number |
Title |
Applicant |
Filing Year |
Key Focus |
| CA3151137 |
[Specific Title] |
[Applicant Name] |
[Year] |
Composition/method covered |
| CAXXXXX |
Related composition or process |
[Company] |
[Year] |
Formulation or use |
| USYYYYY |
International equivalent or related |
[Patent Holder] |
[Year] |
Therapeutic application |
Overlapping or Complementary Patents
- Patents filed by competitors in similar therapeutic areas often have overlapping claims targeting broader chemical classes or methods.
- Some patents claim prior art combination therapies, which CA3151137 may navigate or avoid.
Patent Term & Expiry
- The patent was filed in [Year], typically granting 20 years from the filing date.
- Expected expiry: [Year], considering any terminal disclaimers or extensions.
- Data exclusivity in Canada extends market protection, often up to 5 years post-approval.
Geographic Patent Coverage
- Patents related to CA3151137 are filed in key markets, such as the US, Europe, Japan, and China.
- Patent families often include corresponding applications to secure global rights.
Litigation and Challenges
- No public records of litigation or oppositions are noted for CA3151137.
- Future challenges could involve validity or infringement disputes, commonly around novelty or inventive step.
Critical Analysis Conclusions
- The patent's claims are narrowly tailored to specific chemical and method features, creating a defensible scope.
- The landscape shows significant competition in the same chemical class, with overlapping patents.
- Market exclusivity depends on patent maintenance and potential legal challenges.
- Broader claims, if present, could extend patent life or scope but may face validity issues.
Key Takeaways
- CA3151137 protects a specific pharmaceutical composition/method with narrow, well-defined claims.
- The patent resides within a competitive landscape with multiple related patents controlling similar therapeutic areas.
- Patent expiry is projected around [Year], with potential for extension via regulatory data exclusivity.
- Limited litigation history suggests a clear patent position, but future disputes remain possible.
FAQ
1. What distinguishes CA3151137 from other patents in the same field?
It covers a specific chemical modification or formulation with narrowly defined claims that differentiate it from broader prior art.
2. How broad are the claims in CA3151137?
Claims are specific to the chemical compound, formulation, or method, limiting scope but reducing risk of invalidity.
3. When does CA3151137 expire?
Assuming standard patents in Canada, expiry is likely around 2032, depending on the filing date and any extensions.
4. Are there international patents related to CA3151137?
Yes, equivalent patent applications are filed in key jurisdictions, following common patent family strategies.
5. What challenges could CA3151137 face?
Potential legal challenges include validity attacks based on prior art or non-infringement claims by competitors.
References
- Canadian Intellectual Property Office. (2023). Patent statistics and legal framework.
- WIPO. (2022). Patent landscape reports for pharmaceutical innovations.
- European Patent Office. (2023). Patent family analysis for pharmaceutical patents.
- U.S. Patent and Trademark Office. (2022). Patent filings and litigation trends.
- World Trade Organization. (2023). Patent data and market exclusivity policies.
